Jean‐Luc Pagani

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Dominique Sanglard, Karl Kuchler, Françoise Ischer et al. · Antimicrobial Agents and Chemotherapy · 1995 · 814 citations · Full text

Specific Multidrug Transporters, Antifungal Agent, Azole Resistance +15

Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users

Patrick Boerlin, Franziska Boerlin-Petzold, Christian Durussel et al. · Journal of Clinical Microbiology · 1995 · 96 citations · Full text

Medical Microbiology, Oral Cavities, Germ Tube-positive Candida +9

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Bruno François, Hasan S. Jafri, Jean Chastre et al. · The Lancet Infectious Diseases · 2021 · 80 citations · Full text

Pilot Trial, Clinical Effectiveness, Patient Safety +6

Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting

Patrick Boerlin, Franziska Boerlin-Petzold, Jérôme Goudet et al. · Journal of Clinical Microbiology · 1996 · 79 citations · Full text

Diagnostic Mycology, Oral Isolates, Vitro Susceptibility +12

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia

Yok‐Ai Que, Hedvika Lazar, Michel Wolff et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2014 · 75 citations · Full text

Immunology, Adjunctive Immunotherapy, Respiratory Infection +5